| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.9 |